CytomX Therapeutics (CTMX) Price-to-Earnings (P/E) Ratio
Price: $0.5431
Market Cap: $43.50M
Avg Volume: 1.83M
Market Cap: $43.50M
Avg Volume: 1.83M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Price-to-Earnings (P/E) Ratio Summary
CytomX Therapeutics's P/E ratios across different time periods:
- TTM: 1.44
- Annual: 2.73
- Quarterly: 1.15
What is P/E Ratio?
The Price-to-Earnings (P/E) ratio is a valuation metric that compares a company's stock price to its earnings per share (EPS). It indicates how much investors are willing to pay for each dollar of company earnings.
Related Metrics
- Price-to-Book (P/B) Ratio: -190.73
- Price-to-Sales (P/S) Ratio: 0.63
Annual Ratios
CytomX Therapeutics Historical P/E Ratio
Historical P/B Ratio
Historical P/S Ratio
TTM P/E Ratio
1.44
P/B Ratio (Annual)
-190.73
P/S Ratio (Annual)
0.63
CytomX Therapeutics Historical Valuation Metrics
The table below shows various valuation metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | P/E Ratio | P/B Ratio | P/S Ratio |
|---|---|---|---|
| 2024 | 2.73 | -190.73 | 0.63 |
| 2023 | -201.06 | -2.41 | 1.13 |
| 2022 | -1.08 | -1.23 | 1.98 |
| 2021 | -3.44 | 3.11 | 3.99 |
| 2020 | -9.19 | 6.07 | 3.01 |
| 2019 | -3.68 | 7.37 | 6.55 |
| 2018 | -7.44 | 4.81 | 10.57 |
| 2017 | -18.20 | 11.23 | 10.95 |
| 2016 | -6.76 | 5.07 | 26.47 |
| 2015 | -5.07 | 1.42 | 23.26 |
| 2014 | -14.86 | -5.74 | 88.74 |
| 2013 | -29.75 | -10.17 | 507.35 |
Related Metrics
Explore detailed financial metrics and analysis for CTMX.